OnCusp Therapeutics Funding: $139M Raised

OnCusp Therapeutics funding overview

OnCusp Therapeutics is a Biotech company. OnCusp Therapeutics has raised $139M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for OnCusp Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, OrbiMed, F-Prime Capital, Sofinnova Investments, Catalio Capital Management, Marshall Wace and 4 others. 10 distinct backers are named across the disclosed rounds.

OnCusp Therapeutics at a glance

Total raised: $139M
Latest round date: January 2024
Industry: Biotech
Notable investors: Novo Holdings, OrbiMed, F-Prime Capital, Sofinnova Investments, Catalio Capital Management, Marshall Wace, Forge Life Science Partners, Blackbird BioVentures

Frequently asked about OnCusp Therapeutics funding

How much has OnCusp Therapeutics raised?: OnCusp Therapeutics has raised $139M in total disclosed funding across the rounds on record.
Who has invested in OnCusp Therapeutics?: Novo Holdings, OrbiMed, F-Prime Capital, Sofinnova Investments, Catalio Capital Management, Marshall Wace are named among the investors backing OnCusp Therapeutics.
What was the latest OnCusp Therapeutics funding round?: No round stage has been disclosed for OnCusp Therapeutics.
Where is OnCusp Therapeutics based?: No headquarters location is disclosed for OnCusp Therapeutics.
What sector does OnCusp Therapeutics operate in?: OnCusp Therapeutics is tracked under Biotech, with $139M in disclosed funding.
When did OnCusp Therapeutics last raise?: The last disclosed OnCusp Therapeutics round closed in January 2024.

OnCusp Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies below to benchmark round size and investor mix.

OnCusp Therapeutics Funding: $139M Raised

OnCusp Therapeutics funding overview

OnCusp Therapeutics at a glance

Frequently asked about OnCusp Therapeutics funding

OnCusp Therapeutics founders (1)

Companies related to OnCusp Therapeutics (35)

Browse related funding lists (6)